JCVWX
Price
$22.45
Change
-$0.17 (-0.75%)
Updated
Jul 31 closing price
Net Assets
544.6M
RMEBX
Price
$64.44
Change
+$0.03 (+0.05%)
Updated
Jul 31 closing price
Net Assets
118.05B
Interact to see
Advertisement

JCVWX vs RMEBX

JCVWX vs RMEBX Comparison Chart in %
View a ticker or compare two or three
VS
JCVWX vs. RMEBX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JCVWX is a StrongBuy and RMEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 118B vs. JCVWX (545M). JCVWX pays higher dividends than RMEBX: JCVWX (1.97) vs RMEBX (0.99). JCVWX was incepted earlier than RMEBX: JCVWX (15 years) vs RMEBX (12 years). RMEBX (1.07) is less costly to investors than JCVWX (0.76). RMEBX is a more actively managed with annual turnover of: 30.00 vs. JCVWX (13.00). RMEBX has a lower initial minimum investment than JCVWX: RMEBX (250) vs JCVWX (1000000). RMEBX annual gain was more profitable for investors over the last year : 8.96 vs. JCVWX (-5.40). RMEBX return over 5 years is better than : 36.13 vs. JCVWX (-35.93).
JCVWXRMEBXJCVWX / RMEBX
Total Expense Ratio0.751.0770%
Annual Report Gross Expense Ratio0.761.0771%
Fund Existence15 years12 years-
Gain YTD15.0109.416159%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets545M118B0%
Annual Yield % from dividends1.970.99198%
Returns for 1 year-5.408.96-60%
Returns for 3 years-33.0032.63-101%
Returns for 5 years-35.9336.13-99%
Returns for 10 years4.2190.645%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IEOTX15.100.17
+1.14%
Voya Large Cap Growth Port S2
JRAAX88.86N/A
N/A
Janus Henderson Research A
VLLIX45.39-0.03
-0.07%
Value Line Larger Companies Focus Instl
BHCFX21.68-0.10
-0.46%
Baron Health Care Retail
FBDIX193.96-3.99
-2.02%
Franklin Biotechnology Discovery A